{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T20:26:21Z","timestamp":1769113581167,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T00:00:00Z","timestamp":1727481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T00:00:00Z","timestamp":1727481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303474"],"award-info":[{"award-number":["82303474"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2022M720176"],"award-info":[{"award-number":["2022M720176"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-024-02035-8","type":"journal-article","created":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T06:01:56Z","timestamp":1727503316000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clarifying new molecular subtyping and precise treatment of melanoma based on disulfidptosis-related lncRNA signature"],"prefix":"10.1186","volume":"29","author":[{"given":"Yue","family":"Lei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yilin","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yihang","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shukang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,28]]},"reference":[{"issue":"1","key":"2035_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7\u201330.","journal-title":"CA Cancer J Clin"},{"key":"2035_CR2","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.semcancer.2019.08.002","volume":"59","author":"M Marzagalli","year":"2019","unstructured":"Marzagalli M, Ebelt ND, Manuel ER. Unraveling the crosstalk between melanoma and immune cells in the tumor microenvironment. Semin Cancer Biol. 2019;59:236\u201350.","journal-title":"Semin Cancer Biol"},{"issue":"8","key":"2035_CR3","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1016\/j.jid.2022.01.025","volume":"142","author":"E Brenner","year":"2022","unstructured":"Brenner E, Rocken M. A commotion in the skin: developing melanoma immunotherapies. J Invest Dermatol. 2022;142(8):2055\u201360.","journal-title":"J Invest Dermatol"},{"issue":"6","key":"2035_CR4","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.immuni.2016.06.001","volume":"44","author":"JM Pitt","year":"2016","unstructured":"Pitt JM, Vetizou M, Daillere R, Roberti MP, Yamazaki T, Routy B, et al. Resistance mechanisms to immune-checkpoint blockade in cancer: tumor-intrinsic and -extrinsic factors. Immunity. 2016;44(6):1255\u201369.","journal-title":"Immunity"},{"issue":"1","key":"2035_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/bjc.2017.434","volume":"118","author":"RW Jenkins","year":"2018","unstructured":"Jenkins RW, Barbie DA, Flaherty KT. Mechanisms of resistance to immune checkpoint inhibitors. Br J Cancer. 2018;118(1):9\u201316.","journal-title":"Br J Cancer"},{"issue":"1","key":"2035_CR6","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/s41467-021-21207-2","volume":"12","author":"M Garg","year":"2021","unstructured":"Garg M, Couturier DL, Nsengimana J, Fonseca NA, Wongchenko M, Yan Y, et al. Tumour gene expression signature in primary melanoma predicts long-term outcomes. Nat Commun. 2021;12(1):1137.","journal-title":"Nat Commun"},{"issue":"4","key":"2035_CR7","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/s41556-020-0496-x","volume":"22","author":"X Liu","year":"2020","unstructured":"Liu X, Olszewski K, Zhang Y, Lim EW, Shi J, Zhang X, et al. Cystine transporter regulation of pentose phosphate pathway dependency and disulfide stress exposes a targetable metabolic vulnerability in cancer. Nat Cell Biol. 2020;22(4):476\u201386.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"2035_CR8","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s10020-023-00739-x","volume":"29","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Wei Y, Fan L, Nie Y, Li J, Zeng R, et al. Leveraging a disulfidptosis-related signature to predict the prognosis and immunotherapy effectiveness of cutaneous melanoma based on machine learning. Mol Med. 2023;29(1):145.","journal-title":"Mol Med"},{"key":"2035_CR9","doi-asserted-by":"publisher","DOI":"10.2217\/mmt-2023-0006","author":"L Yang","year":"2023","unstructured":"Yang L, Cao ZJ, Zhang Y, Zhou JK, Tian J. Disulfidptosis-related classification patterns and tumor microenvironment characterization in skin cutaneous melanoma. Melanoma Manag. 2023. https:\/\/doi.org\/10.2217\/mmt-2023-0006.","journal-title":"Melanoma Manag"},{"issue":"5","key":"2035_CR10","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.tem.2023.02.007","volume":"34","author":"K Xu","year":"2023","unstructured":"Xu K, Xia P, Chen X, Ma W, Yuan Y. ncRNA-mediated fatty acid metabolism reprogramming in HCC. Trends Endocrinol Metab. 2023;34(5):278\u201391.","journal-title":"Trends Endocrinol Metab"},{"issue":"12","key":"2035_CR11","first-page":"6256","volume":"13","author":"L Yu","year":"2023","unstructured":"Yu L, Li J, Xiao M. LncRNA SLC7A11-AS1 stabilizes CTCF by inhibiting its UBE3A-mediated ubiquitination to promote melanoma metastasis. Am J Cancer Res. 2023;13(12):6256\u201369.","journal-title":"Am J Cancer Res"},{"issue":"1","key":"2035_CR12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13062-023-00370-0","volume":"18","author":"C Liu","year":"2023","unstructured":"Liu C, Xu K, Liu J, He C, Liu P, Fu Q, et al. LncRNA RP11\u2013620J15.3 promotes HCC cell proliferation and metastasis by targeting miR-326\/GPI to enhance glycolysis. Biol Direct. 2023;18(1):15.","journal-title":"Biol Direct"},{"key":"2035_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2024.107930","volume":"169","author":"K Xu","year":"2024","unstructured":"Xu K, Dai C, Yang J, Xu J, Xia C, Li J, et al. Disulfidptosis-related lncRNA signatures assess immune microenvironment and drug sensitivity in hepatocellular carcinoma. Comput Biol Med. 2024;169: 107930.","journal-title":"Comput Biol Med"},{"issue":"1","key":"2035_CR14","doi-asserted-by":"publisher","first-page":"20781","DOI":"10.1038\/s41598-022-25356-2","volume":"12","author":"K Xu","year":"2022","unstructured":"Xu K, Xia P, Liu P, Zhang X. A six lipid metabolism related gene signature for predicting the prognosis of hepatocellular carcinoma. Sci Rep. 2022;12(1):20781.","journal-title":"Sci Rep"},{"key":"2035_CR15","doi-asserted-by":"publisher","DOI":"10.1093\/jleuko\/qiae023","author":"M Di Simone","year":"2024","unstructured":"Di Simone M, Corsale AM, Toia F, Shekarkar Azgomi M, Di Stefano AB, Lo Presti E, et al. Tumor-infiltrating gammadelta T cells as targets of immune checkpoint blockade in melanoma. J Leukoc Biol. 2024. https:\/\/doi.org\/10.1093\/jleuko\/qiae023.","journal-title":"J Leukoc Biol"},{"key":"2035_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-007612","author":"V Vallacchi","year":"2024","unstructured":"Vallacchi V, Vergani E, Cossa M, Gargiuli C, Busico A, Devecchi A, et al. Multistep tumor genetic evolution and changes in immunogenicity trigger immune-mediated disease eradication in stage IV melanoma: lessons from a single case. J Immunother Cancer. 2024. https:\/\/doi.org\/10.1136\/jitc-2023-007612.","journal-title":"J Immunother Cancer"},{"key":"2035_CR17","doi-asserted-by":"publisher","DOI":"10.1097\/CMR.0000000000000958","author":"RJ Teixeira","year":"2024","unstructured":"Teixeira RJ, de Souza VG, Sorroche BP, Paes VG, Zambuzi-Roberto FA, Pereira CAD, et al. Immunohistochemistry assessment of tissue neutrophil-to-lymphocyte ratio (tNLR) predicts outcomes in melanoma patients treated with anti-programmed cell death 1 therapy. Melanoma Res. 2024. https:\/\/doi.org\/10.1097\/CMR.0000000000000958.","journal-title":"Melanoma Res"},{"key":"2035_CR18","doi-asserted-by":"publisher","DOI":"10.1097\/CMR.0000000000000957","author":"W Zhang","year":"2024","unstructured":"Zhang W, Wang S. Machine learning developed an intratumor heterogeneity signature for predicting prognosis and immunotherapy benefits in skin cutaneous melanoma. Melanoma Res. 2024. https:\/\/doi.org\/10.1097\/CMR.0000000000000957.","journal-title":"Melanoma Res"},{"key":"2035_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.111605","volume":"129","author":"Q Wang","year":"2024","unstructured":"Wang Q, Xiao Z, Hou Z, Li D. Effect of disulfidptosis-related genes SLC3A2, SLC7A11 and FLNB polymorphisms on risk of autoimmune thyroiditis in a Chinese population. Int Immunopharmacol. 2024;129: 111605.","journal-title":"Int Immunopharmacol"},{"key":"2035_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2024.113601","volume":"200","author":"M Egeler","year":"2024","unstructured":"Egeler M, Lai-Kwon J, Tissier R, Fraterman I, Kuijpers A, Van Houdt W, et al. Real-world health-related quality of life outcomes for patients with resected stage III\/IV melanoma treated with adjuvant anti-PD1 therapy. Eur J Cancer. 2024;200: 113601.","journal-title":"Eur J Cancer"},{"key":"2035_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16030536","author":"G Manneschi","year":"2024","unstructured":"Manneschi G, Caldarella A, Caini S, Checchi S, Intrieri T, Chiarugi A, et al. The burden of thin melanomas in Tuscany, Italy, 1985\u20132017: age and sex-specific temporal trends in incidence and mortality. Cancers. 2024. https:\/\/doi.org\/10.3390\/cancers16030536.","journal-title":"Cancers"},{"key":"2035_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16030606","author":"L Nanz","year":"2024","unstructured":"Nanz L, Keim U, Katalinic A, Meyer T, Garbe C, Leiter U. Epidemiology of keratinocyte skin cancer with a focus on cutaneous squamous cell carcinoma. Cancers. 2024. https:\/\/doi.org\/10.3390\/cancers16030606.","journal-title":"Cancers"},{"key":"2035_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-024-02959-9","author":"BM Arockiaraj","year":"2024","unstructured":"Arockiaraj BM, Cahoon EK, Sargen MR, Long E, Tucker MA, Mai JZ. Ambient ultraviolet radiation and ocular melanoma incidence in the United States 2000\u20132019. Eye. 2024. https:\/\/doi.org\/10.1038\/s41433-024-02959-9.","journal-title":"Eye"},{"key":"2035_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25031582","author":"F Cassalia","year":"2024","unstructured":"Cassalia F, Danese A, Tudurachi I, Federico S, Zambello A, Guidotti A, et al. PRAME updated: diagnostic, prognostic, and therapeutic role in skin cancer. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25031582.","journal-title":"Int J Mol Sci"},{"key":"2035_CR25","doi-asserted-by":"publisher","first-page":"1285895","DOI":"10.3389\/fimmu.2023.1285895","volume":"14","author":"K Amrane","year":"2023","unstructured":"Amrane K, Le Meur C, Besse B, Hemon P, Le Noac\u2019h P, Pradier O, et al. HLA-DR expression in melanoma: from misleading therapeutic target to potential immunotherapy biomarker. Front Immunol. 2023;14:1285895.","journal-title":"Front Immunol"},{"key":"2035_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16030583","author":"J Sun","year":"2024","unstructured":"Sun J, Karasaki KM, Farma JM. The use of gene expression profiling and biomarkers in melanoma diagnosis and predicting recurrence: implications for surveillance and treatment. Cancers. 2024. https:\/\/doi.org\/10.3390\/cancers16030583.","journal-title":"Cancers"},{"issue":"1","key":"2035_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0290986","volume":"19","author":"Y Liu","year":"2024","unstructured":"Liu Y, Wang S, Wei S, Qiu X, Mei Y, Yan L. The promotive role of lncRNA MIR205HG in proliferation, invasion, and migration of melanoma cells via the JMJD2C\/ALKBH5 axis. PLoS ONE. 2024;19(1): e0290986.","journal-title":"PLoS ONE"},{"issue":"2","key":"2035_CR28","doi-asserted-by":"publisher","first-page":"265","DOI":"10.7150\/ijms.84072","volume":"21","author":"M Luo","year":"2024","unstructured":"Luo M, Lei R, Zhao Q, Shen Y, He Z, Xu J. LINC00662 promotes melanoma progression by competitively binding miR-107 and activating the beta-catenin signaling pathway. Int J Med Sci. 2024;21(2):265\u201376.","journal-title":"Int J Med Sci"},{"key":"2035_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116213","volume":"172","author":"Y Zhan","year":"2024","unstructured":"Zhan Y, Yang Z, Zeng H, Yu J, Chen X, Wu Y. Extracellular vesicle-derived non-coding RNAs in remodeling melanoma. Biomed Pharmacother. 2024;172: 116213.","journal-title":"Biomed Pharmacother"},{"key":"2035_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106600","volume":"84","author":"X Zhang","year":"2020","unstructured":"Zhang X, Ren L, Yan X, et al. Identification of immune-related lncRNAs in periodontitis reveals regulation network of gene-lncRNA-pathway-immunocyte. Int Immunopharmacol. 2020;84: 106600.","journal-title":"Int Immunopharmacol"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-024-02035-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-024-02035-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-024-02035-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T06:10:39Z","timestamp":1727503839000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-024-02035-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,28]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2035"],"URL":"https:\/\/doi.org\/10.1186\/s40001-024-02035-8","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,28]]},"assertion":[{"value":"19 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"468"}}